Previous studies have shown that TP53 is the most frequently mutated gene in triple-negative breast cancer (TNBC), is more common in the Basal subtype, and has emerged as a major contributor to the suppression of innate immune signaling and promotion of immune escape (40–43). Here, TP53 is linked to triple-negative breast carcinoma.